Lupron Depot, a brand-name medication used to treat conditions like prostate cancer, endometriosis, and uterine fibroids, received its initial U.S. Food and Drug Administration (FDA) approval on December 20, 1985 [1].
When does Lupron Depot's patent expire?
The patent landscape for Lupron Depot is complex, with multiple patents covering various aspects of the drug and its delivery system. While initial patents have expired, other patents may still be in force, affecting generic entry. Information on specific patent expiry dates can be found on resources like DrugPatentWatch.com [2].
Who manufactures Lupron Depot?
Lupron Depot is manufactured by AbbVie Inc. [3].
What are the alternatives to Lupron Depot?
Several therapeutic alternatives exist for the conditions treated by Lupron Depot. These can include other gonadotropin-releasing hormone (GnRH) agonists, GnRH antagonists, or surgical interventions, depending on the specific indication and patient profile [4].
Can generic versions of Lupron Depot be made?
The availability of generic versions of Lupron Depot is contingent upon patent expiries and regulatory approvals. The complex nature of drug patents, including formulation and method-of-use patents, can influence when and if generic competition emerges [2].
What are the side effects associated with Lupron Depot?
Common side effects of Lupron Depot can include hot flashes, fatigue, and injection site reactions. More serious side effects can occur, and patients should discuss potential risks with their healthcare provider [5].
How is Lupron Depot administered?
Lupron Depot is administered as an intramuscular injection [6]. The depot formulation is designed to release the medication slowly over a specified period, reducing the frequency of dosing.
What is the mechanism of action for Lupron Depot?
Lupron Depot is a synthetic analog of gonadotropin-releasing hormone (GnRH). Initially, it stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to a surge in testosterone or estrogen. However, with continuous administration, it suppresses the pituitary gland's release of LH and FSH, thereby reducing testosterone or estrogen levels to castrate levels [7].
What conditions does Lupron Depot treat?
Lupron Depot is approved for the palliative treatment of advanced prostate cancer, the treatment of endometriosis, and the treatment of uterine fibroids [1]. It is also used for central precocious puberty [8].
What is the difference between Lupron Depot and other GnRH agonists?
While other GnRH agonists share a similar mechanism of action, differences can exist in their chemical structures, pharmacokinetic profiles, approved indications, dosing frequencies, and potential side effect profiles. These distinctions can influence their clinical use and patient selection [7].
What clinical data supports Lupron Depot's use?
Clinical trials have demonstrated the efficacy of Lupron Depot in reducing testosterone or estrogen levels and managing symptoms associated with its approved indications. Long-term studies have also assessed its safety profile and impact on disease progression [4, 5].
What are the risks of using Lupron Depot during pregnancy?
Lupron Depot can cause harm to an unborn baby and should not be used by pregnant women. Effective non-hormonal contraception is recommended during treatment and for a period after the last dose [9].
---
Sources:
1. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.generalinfo&productid=64146
2. https://drugpatentwatch.com/
3. https://www.abbvie.com/
4. https://www.ncbi.nlm.nih.gov/books/NBK562220/
5. https://www.mayoclinic.org/drugs-supplements/leuprolide-injection-route/side-effects/dr-20068499
6. https://www.webmd.com/drugs/2/drug-6741/lupron-depot-injection/details
7. https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate
8. https://www.medscape.com/viewarticle/425514_4
9. https://www.rxlist.com/lupron-depot-side-effects-drug-center.htm